Lymphocyte activation antigen CD70 expressed by renal cell carcinoma is a potential therapeutic target for anti-CD70 antibody-drug conjugates.
Law, Che-Leung
Lymphocyte activation antigen CD70 expressed by renal cell carcinoma is a potential therapeutic target for anti-CD70 antibody-drug conjugates. [electronic resource] - Cancer research Feb 2006 - 2328-37 p. digital
Publication Type: Journal Article
0008-5472
10.1158/0008-5472.CAN-05-2883 doi
Animals
Antigens, CD--biosynthesis
Antineoplastic Agents--administration & dosage
Apoptosis--drug effects
CD27 Ligand
Carcinoma, Renal Cell--drug therapy
Cell Cycle--drug effects
Humans
Immunoconjugates--immunology
Immunohistochemistry
Kidney Neoplasms--drug therapy
Lymphocyte Activation
Membrane Proteins--biosynthesis
Mice
Mice, Nude
Microtubules--drug effects
Oligopeptides--administration & dosage
Phenylalanine--analogs & derivatives
RNA, Messenger--biosynthesis
Tumor Necrosis Factors--biosynthesis
Xenograft Model Antitumor Assays
Lymphocyte activation antigen CD70 expressed by renal cell carcinoma is a potential therapeutic target for anti-CD70 antibody-drug conjugates. [electronic resource] - Cancer research Feb 2006 - 2328-37 p. digital
Publication Type: Journal Article
0008-5472
10.1158/0008-5472.CAN-05-2883 doi
Animals
Antigens, CD--biosynthesis
Antineoplastic Agents--administration & dosage
Apoptosis--drug effects
CD27 Ligand
Carcinoma, Renal Cell--drug therapy
Cell Cycle--drug effects
Humans
Immunoconjugates--immunology
Immunohistochemistry
Kidney Neoplasms--drug therapy
Lymphocyte Activation
Membrane Proteins--biosynthesis
Mice
Mice, Nude
Microtubules--drug effects
Oligopeptides--administration & dosage
Phenylalanine--analogs & derivatives
RNA, Messenger--biosynthesis
Tumor Necrosis Factors--biosynthesis
Xenograft Model Antitumor Assays